ICP-332 Tablets Clinical Trials
5 recruitingDrug
Phase 23Phase 33Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria (CSU)
Beijing InnoCare Pharma Tech Co., Ltd.344 enrolled30 locationsNCT07378527
Recruiting
Phase 2
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Beijing InnoCare Pharma Tech Co., Ltd.172 enrolled1 locationNCT07251998
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Phase 2Phase 3
ICP-332 in Subjects With Non-segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.603 enrolled45 locationsNCT07047612
Recruiting
Phase 1
Phase I Study of ICP-332 in Healthy Subjects
Healthy Subjects
InnoCare Pharma Inc.24 enrolled1 locationNCT06530966